US FDA REJECTS OCUGEN’S REQUEST FOR EMERGENCY USE AUTHORISATION FOR COVAXIN

Highlights

• The Hyderabad-based company said that the BLA path is for full approval instead of emergency use authorization and all applications have to follow the BLA process

• Few weeks back, Ocugen, had submitted a "Master File" to the US Food and Drug Administration

According to the statement issued by Bharat Biotech, an application made by its  partner Ocugen regarding emergency use a....